華鈺礦業(601020.SH):西藏博實減持時間區間屆滿 累計減持3.67%股份
格隆匯11月25日丨華鈺礦業(601020.SH)公佈,截至本公告披露日,持有公司5%以上股東西藏博實創業投資有限責任公司(以下簡稱“西藏博實”)持有公司無限售流通股3223.33萬股,佔公司總股本比例6.1290%,股份來源為公司首次公開發行股票並上市前已發行的股份。
截至本公告披露日,減持時間區間屆滿,西藏博實使用集中競價交易方式、大宗交易方式累計減持股份1929.09萬股,佔公司總股本的3.6681%,現持有公司股份3223.3333萬股,佔公司總股本的6.1290%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.